Y, C., B, L., & D, Y. (2026). Fatty Acid Degradation (FAD) Subtype-Informed Treatment Allocation in Unresectable Hepatocellular Carcinoma (FAD-HCC-01): Protocol for a Prospective Multicentre Proof-of-Concept Study. Journal of hepatocellular carcinoma, 13, 608436. https://doi.org/10.2147/JHC.S608436
Chicago Style (17th ed.) CitationY, Cheng, Li B, and Yu D. "Fatty Acid Degradation (FAD) Subtype-Informed Treatment Allocation in Unresectable Hepatocellular Carcinoma (FAD-HCC-01): Protocol for a Prospective Multicentre Proof-of-Concept Study." Journal of Hepatocellular Carcinoma 13 (2026): 608436. https://doi.org/10.2147/JHC.S608436.
MLA (9th ed.) CitationY, Cheng, et al. "Fatty Acid Degradation (FAD) Subtype-Informed Treatment Allocation in Unresectable Hepatocellular Carcinoma (FAD-HCC-01): Protocol for a Prospective Multicentre Proof-of-Concept Study." Journal of Hepatocellular Carcinoma, vol. 13, 2026, p. 608436, https://doi.org/10.2147/JHC.S608436.